[
  {
    "date": "2023-12-30",
    "symbol": "CVKD",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 8402500,
    "prepaidexpensecurrent": 89673,
    "assetscurrent": 8492173,
    "propertyplantandequipmentnet": 2287,
    "operatingleaserightofuseasset": 20998,
    "otherassetsnoncurrent": 3792,
    "assets": 8519250,
    "accountspayablecurrent": 167319,
    "accruedliabilitiescurrent": 638206,
    "operatingleaseliabilitycurrent": 21350,
    "liabilitiescurrent": 826875,
    "liabilities": 826875,
    "commonstockvalue": 13022,
    "additionalpaidincapitalcommonstock": 22750768,
    "retainedearningsaccumulateddeficit": -15071415,
    "stockholdersequity": 7692375,
    "liabilitiesandstockholdersequity": 8519250,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 75000000,
    "commonstocksharesissued": 13022754,
    "commonstocksharesoutstanding": 13022754,
    "generalandadministrativeexpense": 3549514,
    "researchanddevelopmentexpense": 4081349,
    "depreciation": 1980,
    "operatingexpenses": 7632843,
    "operatingincomeloss": -7632843,
    "investmentincomeinterestanddividend": 249092,
    "investmentincomeinvestmentexpense": 3534,
    "amortizationoffinancingcosts": 13567,
    "fairvalueadjustmentofwarrants": 216095,
    "gainslossesonextinguishmentofdebt": -740139,
    "nonoperatingincomeexpense": -724243,
    "netincomeloss": -8357086,
    "earningspersharebasic": -0.62,
    "weightedaveragenumberofsharesoutstandingbasic": 13491980,
    "earningspersharediluted": -0.62,
    "weightedaveragenumberofdilutedsharesoutstanding": 13491980,
    "stockissuedduringperiodvaluenewissues": 1400,
    "stockissuedduringperiodsharesnewissues": 1400000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 1140,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 1140700,
    "adjustmentstoadditionalpaidincapitalother": 4596039,
    "stockissuedduringperiodvalueother": -1300,
    "stockissuedduringperiodsharesother": 1300000,
    "stockissuedduringperiodvaluestockoptionsexercised": 250,
    "stockissuedduringperiodsharesstockoptionsexercised": 250000,
    "stockissuedduringperiodvaluepurchaseofassets": 600,
    "stockissuedduringperiodsharespurchaseofassets": 600000,
    "stockissuedduringperiodvalueissuedforservices": 77,
    "stockissuedduringperiodsharesissuedforservices": 77340,
    "stockgrantedduringperiodvaluesharebasedcompensation": 61,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 60839,
    "sharebasedcompensation": 710381,
    "amortizationofdebtdiscountpremium": 13567,
    "lesseeoperatingnoncashleaseexpense": 292,
    "issuanceofsharestosettleassetpurchaseagreement": 3000000,
    "increasedecreaseinprepaidexpense": 66958,
    "increasedecreaseindeferredcharges": -672295,
    "increasedecreaseinotheroperatingassets": -2195,
    "increasedecreaseinaccountspayable": -237578,
    "increasedecreaseinaccruedliabilities": -225645,
    "netcashprovidedbyusedinoperatingactivities": -3530323,
    "paymentstoacquirepropertyplantandequipment": 3254,
    "netcashprovidedbyusedininvestingactivities": -3254,
    "proceedsfromissuanceofwarrants": 6494916,
    "proceedsfromwarrantexercises": 250000,
    "repaymentsofrelatedpartydebt": 250000,
    "proceedsfromissuanceinitialpublicoffering": 5408575,
    "netcashprovidedbyusedinfinancingactivities": 11903491,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 8369914,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 8402500,
    "issuanceofcommonsharesforconsultingservices": 1140700,
    "derecognitionofderivativeliabilitiy": 4596039,
    "liquiditypolicytextblock": "Liquidity",
    "emerginggrowthcompanystatuspolicytextblock": "EmergingGrowth Company Status",
    "patentpolicytextblock": "Patents",
    "scheduleofdevelopmentmilestonepaymentstabletextblock": "As additional consideration, the Asset Purchase Agreement initially provided for a cash payment by the Companyto HESP LLC upon achievement of the following development milestone payments, which cash payment was later amended to be a payment inshares of the Companyâ€™s common stock upon consummation of its IPO:",
    "moneymarketfundsatcarryingvalue": 8287843,
    "financialliabilitiesfairvaluedisclosure": 8287843,
    "liabilitiesfairvalueadjustment": 216095,
    "equityfairvalueadjustment": 4596039,
    "accruedprofessionalfeescurrent": 4000,
    "employeerelatedliabilitiescurrent": 596131,
    "otheraccruedliabilitiescurrent": 38075,
    "paymentsforpurchaseofotherassets1": 250000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 200000,
    "saleofstockconsiderationreceivedontransaction": 20095,
    "costofgoodsandservicessold": 220095,
    "operatingleaseliability": 21350,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 22319,
    "lesseeoperatingleaseliabilitypaymentsdue": 22319,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 969,
    "sharebasedcompensationarrangementbysharebasedpaymentawardissuedate": "July - Sept 2022",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardtermsofaward": "July - Sept 2027",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 11500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 84000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercised": 250000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0451,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y3M29D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.707,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1175000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 0.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y7M20D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 584724,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 0.77,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P8Y6M21D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 10808,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 1175000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 0.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y7M20D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 105000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 75000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremaininggranted": "P9Y6M21D",
    "allocatedsharebasedcompensationexpense": 340499,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1175000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -8357086,
    "foreignincometaxexpensebenefitcontinuingoperations": -1754988,
    "incometaxreconciliationstateandlocalincometaxes": -136314,
    "incometaxreconciliationforeignincometaxratedifferential": 27006,
    "effectiveincometaxratereconciliationsharebasedcompensationexcesstaxbenefitamount": 3150,
    "incometaxreconciliationchangeinenactedtaxrate": 17642,
    "effectiveincometaxratereconciliationderivativeliabilities": 141457,
    "incometaxreconciliationtaxsettlementsother": 47,
    "valuationallowancedeferredtaxassetchangeinamount": -1702000,
    "deferredtaxassetsoperatinglosscarryforwards": 1099000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 138000,
    "deferredtaxassetsinprocessresearchanddevelopment": 807000,
    "deferredtaxassetsdeferredgainonsaleleasebacktransaction": 5000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 137000,
    "deferredtaxassetsgross": 2186000,
    "deferredtaxliabilitiesleasingarrangements": 5000,
    "deferredtaxassetsvaluationallowance": 2181000,
    "othernoncashexpense": 4682454,
    "workingscapital": 7665298,
    "interestincomedepositwithfinancialinstitutionincreasedecrease": 250000,
    "numberofoperatingsegments": 1,
    "effectiveincometaxratecontinuingoperations": 0.5,
    "assetacquisitionconsiderationtransferred": 2000000,
    "revenueremainingperformanceobligationpercentage": 0.35,
    "financeleaseprincipalpayments": 2000000,
    "assetsfairvaluedisclosure": 20095,
    "sharesissued": 685000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 0.6,
    "derivativeliabilityfairvalueofcollateral": 339934,
    "commonequitypercentage": 0.6,
    "percentageofsaleofcommonstockindiscount": 0.06,
    "debtinstrumentinterestratestatedpercentage": 0.06,
    "aggregateshares": 11500,
    "warrantsandrightsoutstandingterm": "P5Y",
    "percentageofexerciseprice": 0.6,
    "excessstocksharesissued": 15000,
    "warrantexercisepriceincrease": 1,
    "debtinstrumentunamortizeddiscountpremiumanddebtissuancecostsnet": 740139,
    "operatingleaseexpense": 26555,
    "increasedecreaseinoperatingliabilities": 26003,
    "lesseeoperatingleasediscountrate": 0.12,
    "commonstockvotingrights": "one",
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.0001,
    "saleofstockpercentageofownershipaftertransaction": 0.0999,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 2000000,
    "stockoptionsgrantedsharesterm": "P10Y",
    "equitymethodinvestmentownershippercentage": 0.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 1.09,
    "debtinstrumentfaceamount": 676479,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardrequisiteserviceperiod1": "P1Y4M24D",
    "operatinglosscarryforwards": 4700000,
    "taxcreditcarryforwardamount": 2700000,
    "effectiveincometaxratereconciliationtaxcredits": 0.5,
    "uncertaintaxbenefit": 0.5,
    "rule10b51arradoptedflag": "false",
    "nonrule10b51arradoptedflag": "false",
    "rule10b51arrtrmntdflag": "false",
    "nonrule10b51arrtrmntdflag": "false",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityinteractivedatacurrent": "Yes",
    "icfrauditorattestationflag": "false",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "CADRENAL THERAPEUTICS, INC.",
    "entitycentralindexkey": 1937993,
    "entityfilenumber": "001-41596",
    "entitytaxidentificationnumber": "88-0860746",
    "entityincorporationstatecountrycode": "DE",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityaddressaddressline1": "822 A1A North",
    "entityaddressaddressline2": "Suite 306",
    "entityaddresscityortown": "Ponte Vedra",
    "entityaddressstateorprovince": "FL",
    "entityaddresspostalzipcode": 32082,
    "cityareacode": "(904)",
    "localphonenumber": "300-0701",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "CVKD",
    "securityexchangename": "NASDAQ",
    "auditorname": "WithumSmith+Brown, PC",
    "auditorfirmid": 100,
    "auditorlocation": "East Brunswick, New Jersey"
  },
  {
    "date": "2022-12-30",
    "symbol": "CVKD",
    "period": "FY",
    "cashequivalentsatcarryingvalue": 32586,
    "prepaidexpensecurrent": 22715,
    "deferredofferingcosts": 672295,
    "assetscurrent": 727596,
    "propertyplantandequipmentnet": 1013,
    "operatingleaserightofuseasset": 43578,
    "otherassetsnoncurrent": 5987,
    "assets": 778174,
    "accountspayablecurrent": 404897,
    "accruedliabilitiescurrent": 863564,
    "operatingleaseliabilitycurrent": 22288,
    "convertiblenotespayablecurrent": 43728,
    "liabilitiescurrent": 1334477,
    "convertiblesubordinateddebtnoncurrent": 442960,
    "convertiblelongtermnotespayable": 110380,
    "derivativeliabilitiesnoncurrent": 4379944,
    "accruedenvironmentallosscontingenciesnoncurrent": 40213,
    "operatingleaseliabilitynoncurrent": 21350,
    "liabilities": 6329324,
    "commonstockvalue": 8194,
    "additionalpaidincapital": 1154985,
    "retainedearningsaccumulateddeficit": -6714329,
    "stockholdersequity": -6714329,
    "liabilitiesandstockholdersequity": 778174,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 75000000,
    "commonstocksharesissued": 8193875,
    "commonstocksharesoutstanding": 8193875,
    "generalandadministrativeexpense": 2307503,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 392859,
    "depreciation": 1266,
    "operatingexpenses": 2701628,
    "operatingincomeloss": -2701628,
    "interestexpense": 40192,
    "amortizationoffinancingcostsanddiscounts": 66913,
    "fairvalueadjustmentofwarrants": 3905596,
    "otherexpenses": 4012701,
    "comprehensiveincomenetoftaxincludingportionattributabletononcontrollinginterest": -6714329,
    "earningspersharebasic": -0.85,
    "weightedaveragenumberofsharesoutstandingbasic": 7890507,
    "earningspersharediluted": -0.85,
    "weightedaveragenumberofdilutedsharesoutstanding": 7890507,
    "sharesoutstanding": 8193875,
    "stockissuedduringperiodvaluenewissues": 7950,
    "stockissuedduringperiodsharesnewissues": 7950000,
    "stockissuedduringperiodvaluerestrictedstockawardgross": 928049,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 243875,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 51621,
    "stockissuedduringperiodvalueother": 175559,
    "netincomeloss": -6714329,
    "sharebasedcompensation": 928049,
    "amortizationofdebtdiscountpremium": 66913,
    "increasedecreaseinprepaidexpense": 22715,
    "increasedecreaseindeferredcharges": 672295,
    "increasedecreaseinotheroperatingassets": 5987,
    "increasedecreaseinaccountspayable": 404897,
    "increasedecreaseinotheraccruedliabilities": 863622,
    "increasedecreaseinotheraccountspayableandaccruedliabilities": 40213,
    "netcashprovidedbyusedinoperatingactivities": -1204770,
    "paymentstoacquirepropertyplantandequipment": 2279,
    "netcashprovidedbyusedininvestingactivities": -2279,
    "proceedsfromconvertibledebt": 1011964,
    "proceedsfromissuanceofdebt": 219721,
    "proceedsfromissuanceofcommonstock": 7950,
    "netcashprovidedbyusedinfinancingactivities": 1239635,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 32586,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 32586,
    "noncashrightofuseassetsandoperatingleaseliabilities": 47090,
    "debtissuancecostsincurredduringnoncashorpartialnoncashtransaction": 51621,
    "fairvalueofassetsacquired": 474349,
    "stockissued1": 175559,
    "emerginggrowthcompanystatuspolicytextblock": "Emerging Growth Company StatusÂ ",
    "determinationofthefairvalueofcommonstockpolicytextblock": "Determination of the Fair Value of CommonStockÂ ",
    "patentpolicytextblock": "PatentsÂ ",
    "scheduleofdevelopmentmilestonepaymentstabletextblock": "      Development MilestonesÂ     Milestone  PaymentsÂ       Completion of enrollment of Leeâ€™s Pharmaceutical PhaseÂ 3 clinical trialÂ     $250,000Â       First MAA submitted in the Peopleâ€™s Republic of ChinaÂ     Â 350,000Â       First Commercial Sale to a Third PartyÂ     $1,200,000Â   Â ",
    "derivativeinstrumentsandhedgesliabilities": 4379944,
    "financialliabilitiesfairvaluedisclosure": 4379944,
    "deferredtaxliabilitiesderivatives": 4379944,
    "liabilitiesfairvalueadjustment": 474348,
    "accruedconsultingfees": 165192,
    "compensatedabsencesliability": 605290,
    "otheraccruedliabilitiescurrentandnoncurrent": 93082,
    "accruedliabilitiescurrentandnoncurrent": 863564,
    "completionofenrollmentofleespharmaceuticalphase3clinicaltrial": 250000,
    "firstmaasubmittedinthepeoplesrepublicofchina1": 350000,
    "firstcommercialsaletoathirdparty1": 1200000,
    "convertiblenotespayablerelatedparties": 550000,
    "deferredfinancecostsnet": 107040,
    "convertibledebt": 442960,
    "convertiblenotespayable": 575000,
    "debtissuancecosts1": 464620,
    "convertibledebt1": 110380,
    "notespayable": 250000,
    "debtissuancecosts2": 206272,
    "convertibledebt2": 43728,
    "debtcurrent": 597068,
    "operatingleaseliability": 43638,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 26068,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 22319,
    "lesseeoperatingleaseliabilitypaymentsdue": 48387,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 4749,
    "placementagentwarrant": "Nov 2022",
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 1,
    "warrantsandrightoutstandingmaturitydate": "Earlier of IPO or Nov 2027",
    "commonstockothersharesoutstanding": 276500,
    "commonstockcapitalsharesreservedforfutureissuance": 276500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.040999999999999995,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 5.81,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.625,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 0.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 4578000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 1100000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 0.84,
    "weightedaverageremainingcontractuallifeyearsgranted": 9.57,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgrantdateintrinsicvalue": 4578000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 9.57,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 108330,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 0.64,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": 9.55,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 427629,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 1100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 0.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 9.57,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 4578000,
    "othersellinggeneralandadministrativeexpense": 791247,
    "researchanddevelopmentexpense": 136802,
    "employeebenefitandsharebasedcompensation": 928049,
    "netincomelossattributabletononredeemablenoncontrollinginterest": -6714329,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -6714329,
    "incomelossattributabletoparent": -6714329,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -1410009,
    "incometaxreconciliationstateandlocalincometaxes": -263978,
    "incometaxpermanentdifferences": 8910,
    "employeebenefitsandsharebasedcompensation": 125248,
    "derivativeassetsliabilitiesatfairvaluenet": 1003603,
    "valuationallowancedeferredtaxassetchangeinamount": 536226,
    "deferredtaxassetsoperatinglosscarryforwards": 298000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 44000,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentcosts": 55000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 135000,
    "deferredtaxassetsgross": 532000,
    "deferredtaxliabilitiespropertyplantandequipment": 53000,
    "deferredtaxassetsvaluationallowance": 479000,
    "netincomelossallocatedtogeneralpartners": 6714329,
    "disposalgroupincludingdiscontinuedoperationcash": 4901824,
    "netcashprovidedbyusedinoperatingactivitiescontinuingoperations": 1204770,
    "workingscapital": 606881,
    "excessstocksharesissued": 15000,
    "saleofstockpricepershare": 1,
    "interestincomedepositwithfinancialinstitutionincreasedecrease": 250000,
    "effectiveincometaxratecontinuingoperations": 0.5,
    "assetacquisitionconsiderationtransferred": 2000000,
    "revenueremainingperformanceobligationpercentage": 0.35000000000000003,
    "financeleaseprincipalpayments": 2000000,
    "assetsfairvaluedisclosure": 20095,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 0.6,
    "derivativeliabilityfairvalueofcollateral": 339934,
    "commonequity": 0.6,
    "commonstock": 0.06,
    "debtinstrumentinterestratestatedpercentage": 0.06,
    "aggregateshares": 11500,
    "percentageofexerciseprice": 0.6,
    "extinguishmentofdebtgainlosspersharenetoftax": 1,
    "debtinstrumentconvertibleconversionprice1": 1,
    "debtinstrumentredemptionpricepercentage": 0.2,
    "operatingleaseexpense": 4394,
    "increasedecreaseinoperatingliabilities": 4334,
    "lesseeoperatingleasediscountrate": 0.12,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 2000000,
    "sharesissued": 810000,
    "stockoptionsgrantedsharesterm": "ten",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 1.11,
    "debtinstrumentfaceamount": 1048151,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardrequisiteserviceperiod1": 2.2,
    "stockcompensationexpense": 928049,
    "operatinglosscarryforwardsvaluationallowance": 479000,
    "operatinglosscarryforwards": 1200000,
    "taxcreditcarryforwardamount": 1200000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.8,
    "effectiveincometaxratereconciliationtaxsettlements": 0.5,
    "purchaseaggregateshares": 84000,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddiscountfrommarketpriceofferingdate": 0.06,
    "shareprice": 6,
    "publicofferingpricepercentage": 1.2,
    "otherresearchanddevelopmentexpense": 3000000,
    "sharesofcommonstock": 50000,
    "entityregistrantname": "CADRENAL THERAPEUTICS, INC.",
    "tradingsymbol": "CVKD",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "December 31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1937993,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-41596",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "88-0860746",
    "entityaddressaddressline1": "822 A1A North",
    "entityaddressaddressline2": "Suite 306",
    "entityaddresscityortown": "Ponte Vedra",
    "entityaddressstateorprovince": "Florida",
    "entityaddresspostalzipcode": 32082,
    "cityareacode": "(904)",
    "localphonenumber": "300-0701",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "The Nasdaq Stock Market, LLC",
    "entityinteractivedatacurrent": "Yes",
    "auditorname": "WithumSmith+Brown, PC",
    "auditorlocation": "East Brunswick, New Jersey",
    "auditorfirmid": 100
  }
]